Ablatus Therapeutics

info@ablatus.co.uk

Contact Us

You can contact us by email info@ablatus.co.uk

Click here to ensure you receive the latest updates from Ablatus

Click here to learn more about BETA

Our technology, Bimodal Electric Tissue Ablation (BETA) is next-generation radiofrequency ablation offering larger, more effective ablations with potentially fewer adverse events and at lower cost than RFA.

14 Jan
Ablatus Therapeutics achieves ISO 13485:2016 certification

Ablatus has been certified to ISO 13485:2016 following successful audits with BSI.… | Read more
1 Nov
Ablatus reaches final of east of England Investment Catalyst Pitching Day

We are delighted to announce that David Brooks, our CEO, successfully pitched… | Read more
13 Sep
Article in Medical Technology

We are delighted to be in print in issue 18 of Medical… | Read more
4 Jul
Healthcare revolution: The ten health innovations that could soon be on the NHS

In the 70 years since the NHS was established, medical breakthroughs such… | Read more
11 Jun
Award nomination for New Anglia Capital investee Ablatus

Norfolk and Norwich University Hospital spin-out Ablatus Therapeutics has been shortlisted for… | Read more